Kjaergaard; Kristian
Patent Applications and Registrations
Patent applications and USPTO patent grants for Kjaergaard; Kristian.The latest application filed is for "antibodies specific for hyperphosphorylated tau and methods of use thereof".
Company Profile
9.19.33
- Kjaergaard; Kristian - Valby DK
- KJAERGAARD; Kristian - Ballerup DK
- Kjaergaard; Kristian - Bagsvaerd DK
Patent Activity
| Patent | Date |
|---|---|
| Antibodies Specific For Hyperphosphorylated Tau And Methods Of Use Thereof App 20220177557 - Pedersen; Jan Torleif ; et al. | 2022-06-09 |
| Site Directed Mutagenesis Of Trem-1 Antibodies For Decreasing Viscosity App 20220010012 - HENRIKSEN; Anette ; et al. | 2022-01-13 |
| Antibodies specific for hyperphosphorylated tau and methods of use thereof Grant 11,111,290 - Pedersen , et al. September 7, 2 | 2021-09-07 |
| Therapeutic Antibodies App 20210238300 - Kjaergaard; Kristian ; et al. | 2021-08-05 |
| Site directed mutagenesis of TREM-1 antibodies for decreasing viscosity Grant 11,072,654 - Henriksen , et al. July 27, 2 | 2021-07-27 |
| Anti-C5a receptor antibodies Grant 10,882,916 - Kjaergaard , et al. January 5, 2 | 2021-01-05 |
| Antibodies specific for hyperphosphorylated tau and methods of use thereof Grant 10,647,762 - Pedersen , et al. | 2020-05-12 |
| Antibodies Specific For Hyperphosphorylated Tau And Methods Of Use Thereof App 20200109192 - Pedersen; Jan Torleif ; et al. | 2020-04-09 |
| ANTI-C5a RECEPTOR ANTIBODIES App 20200017599 - Kjaergaard; Kristian ; et al. | 2020-01-16 |
| Antibodies specific for hyperphosphorylated tau and methods of use thereof Grant 10,487,142 - Pedersen , et al. Nov | 2019-11-26 |
| Antibodies Specific For Hyperphosphorylated Tau And Methods Of Use Thereof App 20190284265 - Pedersen; Jan Torleif ; et al. | 2019-09-19 |
| Antibodies Specific For Hyperphosphorylated Tau And Methods Of Use Thereof App 20190284266 - Pedersen; Jan Torleif ; et al. | 2019-09-19 |
| Site Directed Mutagenesis Of Trem-1 Antibodies For Decreasing Viscosity App 20190185560 - HENRIKSEN; Anette ; et al. | 2019-06-20 |
| Anti-C5a receptor antibodies Grant 10,323,097 - Kjaergaard , et al. | 2019-06-18 |
| Antagonistic DR3 Ligands App 20170305994 - Andersen; Mette Dahl ; et al. | 2017-10-26 |
| Antagonistic DR3 ligands Grant 9,737,612 - Andersen , et al. August 22, 2 | 2017-08-22 |
| Antagonistic DR3 ligands Grant 9,713,644 - Andersen , et al. July 25, 2 | 2017-07-25 |
| Therapeutic Antibodies App 20170073421 - Kjaergaard; Kristian ; et al. | 2017-03-16 |
| Factor VIII Fusion Protein App 20170015729 - Bolt; Gert ; et al. | 2017-01-19 |
| Factor VIII fusion protein Grant 9,493,543 - Bolt , et al. November 15, 2 | 2016-11-15 |
| Novel Methods and Antibodies for Treating Coagulapathy App 20160297892 - Heibroch Petersen; Helle ; et al. | 2016-10-13 |
| Human Anti-kir Antibodies App 20150344576 - Moretta; Alessandro ; et al. | 2015-12-03 |
| Human Anti-kir Antibodies App 20150191547 - Moretta; Alessandro ; et al. | 2015-07-09 |
| Human anti-KIR antibodies Grant 8,981,065 - Moretta , et al. March 17, 2 | 2015-03-17 |
| Therapeutic Antibodies App 20150044231 - Kjaergaard; Kristian ; et al. | 2015-02-12 |
| Antagonistic Dr3 Ligands App 20140294853 - Andersen; Mette Dahl ; et al. | 2014-10-02 |
| Anti-C5a receptor antibodies Grant 8,846,045 - Kjaergaard , et al. September 30, 2 | 2014-09-30 |
| Antagonistic DR3 ligands Grant 8,765,130 - Andersen , et al. July 1, 2 | 2014-07-01 |
| Nucleic acids encoding human anti-kir antibodies Grant 8,614,307 - Moretta , et al. December 24, 2 | 2013-12-24 |
| Anti-C5a receptor antibodies Grant 8,613,926 - Kjaergaard , et al. December 24, 2 | 2013-12-24 |
| Antagonistic Dr3 Ligands App 20130336984 - Andersen; Mette Dahl ; et al. | 2013-12-19 |
| Antagonistic Dr3 Ligands App 20130330360 - Andersen; Mette Dahl ; et al. | 2013-12-12 |
| Therapeutic Antibodies App 20130295116 - Zahn; Stefan ; et al. | 2013-11-07 |
| Human Anti-kir Anitbodies App 20130287770 - Moretta; Alessandro ; et al. | 2013-10-31 |
| KIR-Binding Agents and Methods of Use Thereof App 20130143269 - Padkaer; Soren Berg ; et al. | 2013-06-06 |
| Factor VIII Fusion Protein App 20130040889 - Bolt; Gert ; et al. | 2013-02-14 |
| Therapeutic Antibodies App 20130004514 - Zahn; Stefan ; et al. | 2013-01-03 |
| Human Anti-kir Antibodies App 20120208237 - Moretta; Alessandro ; et al. | 2012-08-16 |
| Human anti-KIR antibodies Grant 8,119,775 - Moretta , et al. February 21, 2 | 2012-02-21 |
| Coupling of Antibody Polypeptides at the C-Terminus App 20100113747 - Kjaergaard; Kristian ; et al. | 2010-05-06 |
| Production of Bispecific Antibodies App 20090182127 - Kjaergaard; Kristian ; et al. | 2009-07-16 |
| Human Anti-Kir Antibodies App 20090081240 - Moretta; Alessandro ; et al. | 2009-03-26 |
| Kir-Binding Agents and Methods of Use Thereof App 20090075340 - Padkaer; Soren Berg ; et al. | 2009-03-19 |
| Method of Producing Antibodies App 20080305516 - Kjaergaard; Kristian ; et al. | 2008-12-11 |
| Kir-Binding Agents and Methods of Use Thereof App 20080305117 - Padkaer; Soren Berg ; et al. | 2008-12-11 |
| Humanized tissue factor antibodies App 20050106139 - Svendsen, Ivan ; et al. | 2005-05-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 